Epidemiology, diagnosis and management of patients with biliary dyskinesia and sphincter of Oddi dysfunction: a survey of Indian gastroenterologists

Ameet Mandot; Sandeep Patil; Shivesh Gupta

doi:10.18203/2320-6012.ijrms20230569

Authors

Ameet Mandot Department of Gastroenterology, The Gut Clinic, Citi Tower, The Gut Clinic, Mumbai, Maharashtra, India
Sandeep Patil Department of Gastroenterology, Relief Gastrocare and Endoscopic Clinic, Nashik, Maharashtra, India
Shivesh Gupta Abbott India Ltd., Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20230569

Keywords:

Functional gall bladder disorder, Treatment of biliary dyskinesia, Epidemiology, Cholecystectomy, Sphincter of Oddi dysfunction

Abstract

Background: A cross-sectional, physician-based survey was conducted to address the relative lack of data on the awareness about and management of biliary dyskinesia and sphincter of Oddi dysfunction among Indian gastroenterologists.

Methods: A structured questionnaire containing questions on epidemiology, etiology, clinical presentation, diagnostic investigations, prognosis and management was used. Physician responses were analyzed as descriptive statistics and reported as frequency and percentages.

Results: A total 146 gastroenterologists across 137 cities participated in the survey. Majority (76.0%) of physicians stated that <10% of their patients with cholecystitis get diagnosed with BD, while 84.7% stated that <25% of patients with BD have SOD. SOD and BD were reported to be common in females <50 years. Patients recovering from major surgeries/stroke/heart attack/sepsis/extensive trauma were identified by 53.0% of physicians to be at risk for BD. Majority of physicians (69.4%) reported that irritable bowel syndrome (IBS) was a major risk factor for SOD. Cholescintigraphy and hepatobiliary scintigraphy were investigations of choice for BD and SOD according to 55.5% and 33.6% of physicians, respectively. Sepsis was identified as a frequent complication of BD (45.2%). Laparoscopic cholecystectomy was identified by 64.4% participants to result in partial resolution of symptoms in many patients. Calcium channel blockers and antispasmodics were preferred by 55.9% and 30.8% physicians for functional gall bladder disorder, respectively. IBS was the most common indication for prescribing the antispasmodic pinaverium, with the primary objective of pain relief.

Conclusions: Findings from this survey provide insights for further research on BD and SOD in India.

Metrics

Metrics Loading ...

References

Richmond BK, Walker A. Biliary dyskinesia: Current perspectives and future directions. Am Surg. 2021;87: 954-60.

Crittenden JP, Dattilo JB. Sphincter of Oddi dysfunction. Treasure Island: StatPearls Publishing; 2022.

Afghani E, Lo SK, Covington PS, Cash BD, Pandol SJ. Sphincter of Oddi function and risk factors for dysfunction. Front Nutr. 2017;4:1.

Santhosh S, Mittal BR, Arun S, Sood A, Bhattacharya A, Kochhar R. Quantitative cholescintigraphy with fatty meal in the diagnosis of sphincter of Oddi dysfunction and acalculous cholecystopathy. Indian J Gastroenterol. 2012;31:186-90.

Pop C, Purcăreanu A, Purcărea M, Andronescu D. The functional sphincter of Oddi disorder. J Med Life. 2008;1:118-29.

Whitaker LF, Bosley ME, Refugia JM, Powell MS, McNatt SS, Westcott CJ, et al. Outcomes after laparoscopic cholecystectomy in hyperkinetic biliary dyskinesia. Am Surg. 2022;88:1983-7.

Brandstatter G, Schinzel S, Wurzer H. Influence of spamolytic anagesics on motility of sphincter of Oddi. Dig Dis Sci. 1996;41:1814-8.

lton E, Howell DA, Parsons WG, Qaseem T, Hanson BL. Endoscopic pancreatic sphincterotomy: indications, outcome and a safe stentless technique. Gastrointest Endosc. 1998;47:240-9.

Sabbaghian MS, Rich BS, Rothberger GD, Cohen J, Batash S, Kramer E, et al. Evaluation of surgical outcomes and gallbladder characteristics in patients with biliary dyskinesia. J Gastrointest Surg. 2008;12: 1324-30.

Corazziari E, Shaffer EA, Hogan WJ, Sherman S, Toouli J. Functional disorders of the biliary tract and pancreas. Gut. 1999;45:48-54.

Jeong SU, Lee SK. Obesity and gallbladder diseases. Korean J Gastroenterol. 2012;59:27-34.

Thiels CA, Hanson KT, Chawla KS, Topazian MD, Paley KH, Habermann EB, et al. Functional gallbladder disease: Operative trends and short-term outcomes. Surgery. 2016;160:100-5.

Tarnasky PR. Post-cholecystectomy syndrome and sphincter of Oddi dysfunction: past, present and future. Expert Rev Gastroenterol Hepatol. 2016;10:1359-72.

Evans PR, Bak YT, Dowsett JF, Smith RC, Kellow JE. Small bowel dysmotility in patients with postcholecystectomy sphincter of Oddi dysfunction. Dig Dis Sci. 1997;42:1507-12.

Kalloo AN, Pasricha PJ. Therapy of sphincter of Oddi dysfunction. Gastrointest Endosc Clin N Am. 1996;6: 117-25.

Cotton PB, Elta GH, Carter CR, Pasricha PJ, Corazziari ES. Gallbladder and sphincter of Oddi disorders. Gastroenterology. 2016;150:1420-9.e2.

Cafasso DE, Smith RR. Symptomatic cholelithiasis and functional disorders of the biliary tract. Surg Clin North Am. 2014;94:233-56.

Wilcox CM. Sphincter of Oddi dysfunction Type III: New studies suggest new approaches are needed. World J Gastroenterol. 2015;21:5755-61.

Wilkins T, Agabin E, Varghese J, Talukder A. Gallbladder dysfunction: Cholecystitis, choledocholithiasis, cholangitis, and biliary dyskinesia. Prim Care. 2017;44:575-97.

Corazziari E, Cicala M, Scopinaro F. Scintigraphic assessment of SO dysfunction. Gut 2003;52:1655-6.

Ishikawa S, Ohtaki A, Koyano T, Takahashi T, Sato Y, Nakamura S, et al. Percutaneous transhepatic gallbladder drainage for acute acalculous cholecystitis following cardiovascular surgery. J Cardiovasc Surg. 1997;38:513-5.

Lee R, Ha H, Han YS, Kwon HJ, Ryeom H, Chun JM. Percutaneous transhepatic gallbladder drainage followed by elective laparoscopic cholecystectomy for patients with moderate to severe acute cholecystitis. Medicine. 2017;96(44):e8533.

Sand J, Nordback I, Koskinen M, Matikainen M, Lindholm TS. Nifedipine for suspected Type II sphincter of Oddi dyskinesia. Am J Gastroenterol. 1993;88:530-5.

Kalaitzakis E, Ambrose T, Phillips-Hughes J, Collier J, Chapman RW. Management of patients with biliary sphincter of Oddi disorder without sphincter of Oddi manometry. BMC Gastroenterol. 2010;10:124.

Christen MO. Pinaverium bromide: A calcium antagonist with selectivity for the gastrointestinal tract. Today Ther Trends. 1995;13:47-62.

Scaffidi A, Costa R, Frontespezi S. Effectiveness of pinaverium bromide in the treatment of primitive biliary dyskinesia: 99mTc-P-IDA scintigraphic evaluation. Int J Clin Pharmacol Ther Toxicol. 1987; 25:522-6.

Bor S, Lehert P, Chalbaud A, Tack J. Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2021;14:17562.

Zheng L, Lai Y, Lu W, Li B, Fan H, Yan Z, et al. Pinaverium reduces symptoms of irritable bowel syndrome in a multicenter, randomized, controlled trial. Clin Gastroenterol Hepatol. 2015;13:1285-92e1.